6-pyrimidinyl-pyrimid-4-one derivative
US8198437B2 · kind B2 · utility
2Cited by
3References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 12, 2008 |
| Grant date | Jun 12, 2012 |
| Priority date | — |
| Expiry date | Sep 12, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof:which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g. Alzheimer disease).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.